Researchers conducted a retrospective chart review of 78 patients with severe obesity (class III, BMI ≥ 35 to < 40 or class IV, BMI ≥ 40; mean BMI, 39.9; 51% men) who underwent direct current ...

PHILADELPHIA -- For atrial fibrillation (Afib) patients with obesity, a second set of defibrillation pads for dual direct current cardioversion safely improved the success of the procedure, a ...

The drug-shock strategy was more effective for patients experiencing atrial fibrillation for the first time and for patients younger than 70 years, the researchers said. Both the anti-arrhythmia drug ...

Early stroke and systemic embolism rates in patients following cardioversion for atrial fibrillation (A-fib) are low and comparable between those receiving warfarin or the novel oral anticoagulant ...

LISBON, Portugal—Patients presenting to the emergency department (ED) with new, symptomatic A-fib do not necessarily need to undergo immediate cardioversion, as is now common practice, the RACE 7 ...

But the current study, from Dr Gaetano M De Ferrari (University of Pavia, Italy) and colleagues, suggests that there can be a role for cardioversion in some populations, in this case patients with ...

Warfarin, dabigatran and rivaroxaban are safe periprocedural anticoagulation options for patients undergoing cardioversion or ablation for atrial fibrillation, according to researchers in Canada. “We ...

A team of Ochsner Health cardiologists recently published an article in the Journal of the American Medical Association (JAMA) Cardiology comparing two treatment strategies for patients with atrial ...

Clinical trial finds edoxaban to be equally effective as current use of warfarin. Clinical trial finds edoxaban to be equally effective as current use of warfarin. The results of the largest known ...

Please provide your email address to receive an email when new articles are posted on . Patients with atrial fibrillation who received apixaban before their scheduled cardioversion had a lower risk ...